Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02007746 · ClinicalTrials.gov registry record
Liver Fibrosis in Sickle Cell Disease
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 26
- Enrollment target
NCT02007746 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 26 participants.
The verdict
NCT02007746 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Patients with sickle cell disease many have a number of systemic complications, including liver problems. Some of these liver problems lead to liver fibrosis/cirrhosis, secondary to chronic blood transfusions. The purpose of this study is to investigate FibroScan readings in patients with sickle cell disease and iron overload secondary to blood transfusions, and to correlate the FibroScan results with Ferriscan. A comparison with the results of FibroScan to patients with Sickle cell without known liver disease, who have never been on chronic transfusions and with normal liver function profiles will also be made.The primary hypothesis is that the results of FibroScan will correlate with the results of Ferriscan and liver biopsy.
Interventions
- OTHER Liver transient elastography (Fibroscan)
- OTHER Ferriscan
- PROCEDURE Liver biopsy in iron overloaded subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-07 |
| Est. Completion | 2017-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02007746
The ClinicalTrials.gov registry entry for NCT02007746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Liver transient elastography (Fibroscan) is the first listed.
NCT02007746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02007746 about?
NCT02007746 is a clinical study titled "Liver Fibrosis in Sickle Cell Disease". Patients with sickle cell disease many have a number of systemic complications, including liver problems. Some of these liver problems lead to liver fibrosis/cirrhosis, secondary to chronic blood transfusions. The purpose of this study is to investigate FibroScan readings in patients with sickle cel...
What is the current status of trial NCT02007746?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2012-07. Estimated completion is 2017-06-01.
What interventions are being tested in trial NCT02007746?
The interventions under investigation include: Liver transient elastography (Fibroscan) (OTHER), Ferriscan (OTHER), Liver biopsy in iron overloaded subjects. (PROCEDURE).
Who is sponsoring clinical trial NCT02007746?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.